Albuminuria predicts progression of diastolic dysfunction in patients with cardiovascular risks

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Kyung-Duk Min

Hyogo Medical University, Nishinomiya (Japan)

4 More presentations in this session

Presentation thumbnail

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Doctor R. Miftode (Iasi, RO)

Abstract Slides Video

Presentation thumbnail

Crucial relationship between right ventricular to pulmonary circulation uncoupling and natriuretic peptides levels in heart failure during maximal exercise

Doctor G. Crisci (Hasselt, BE)

Abstract Slides Video

Presentation thumbnail

Correlation of NT-proBNP, copeptin, cystatin C, apelin, sMCAM/sCD146 and ADMA concentration with parameters of volum status in patients with chronic heart failure

Professor F. Malek (Prague, CZ)

Abstract Slides Video

Presentation thumbnail

The impact of apolipoprotein B levels on left ventricular ejection fraction in heart failure patients

Assistant Professor I. Rodean (Targu Mures, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers in heart failure and kidney disease

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

Albuminuria is associated with progression of diastolic dysfunction in patients at risk for cardiovascular disease

Congress Presentation

Albuminuria predicts the progression of diastolic dysfunction in patients at risk for cardiovascular disease

Congress Presentation

Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources